Hank Breslin

Doylestown Hospital — United States

Medicine · Health Sciences

1h-index93citations8works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Mechanisms and Therapy(4), DNA Repair Mechanisms(3), PARP inhibition in cancer therapy(3), Protein Degradation and Inhibitors(3), Chromatin Remodeling and Cancer(3)

Publications8 total

Abstract 2907: A first-in-class series of potent and selective macrocyclic ATR inhibitors
Cancer Research·2025
Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023Open Access
Supplementary Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023Open Access
Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023Open Access
Supplementary Data from Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
2023Open Access
Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors
Cancer Research·2019· 92 citedOpen Access
Abstract A16: Potent and selective ATR inhibitors for the treatment of homologous-recombination deficient and PARPi-resistant cancers
Molecular Cancer Research·2017
Abstract 1226: Highly specific ATR inhibitors as a therapeutic approach for a broad spectrum of cancers
Cancer Research·2016· 1 cited

Frequent Co-authors

Oren Gilad(8), Christopher Jackson(5), Seth Noorbakhsh(5), Ranjini K. Sundaram(5), Aravind Kalathil(5), Sachita Ganesa(5), Danielle M. Burgenske(5), Jann N. Sarkaria(5), Ranjit S. Bindra(5), Lanqi Jia(5), Tina Gill(3), Erin George(3), Fiona Simpkins(3), Eric J. Brown(3), Laura Butler(2), Ryan L. Ragland(2), Lanqi Jia(1), Molly M. Hansbarger(1), Stephen J. Rocca(1), Inna Rom(1)